These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17617284)

  • 21. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
    Prenner BM; Capano D; Harris AG
    Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects.
    Pradhan S; Abhishek K; Mah F
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1135-40. PubMed ID: 19630694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: an open-label study.
    Dogru M; Ozmen A; Ertürk H; Sanli O; Karatas A
    Clin Ther; 2002 Aug; 24(8):1309-21. PubMed ID: 12240781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
    Su MY; Perry HD; Barsam A; Perry AR; Donnenfeld ED; Wittpenn JR; D'Aversa G
    Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
    Salmun LM; Herron JM; Banfield C; Padhi D; Lorber R; Affrime MB
    Clin Ther; 2000 May; 22(5):613-21. PubMed ID: 10868558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of loratadine and terfenadine in allergic seasonal rhinoconjunctivitis with emphasis on nasal stuffiness and peak flow.
    Olsen OT; Nüchel Petersen L; Høi L; Lorentzen KA; Hindberg Rasmussen W; Svendsen UG
    Arzneimittelforschung; 1992 Oct; 42(10):1227-31. PubMed ID: 1472143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Ratner P; Hampel F; Van Bavel J; Howland W
    Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial.
    Fukushima A; Ebihara N
    Adv Ther; 2014 Oct; 31(10):1045-58. PubMed ID: 25269854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Loratadine in the treatment of seasonal allergic rhinitis].
    Buko Z; Siergiejko Z; Chyrek-Borowska S
    Otolaryngol Pol; 1994; 48(5):428-34. PubMed ID: 7808748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of nonpharmacologic treatments for acute seasonal allergic conjunctivitis.
    Bilkhu PS; Wolffsohn JS; Naroo SA; Robertson L; Kennedy R
    Ophthalmology; 2014 Jan; 121(1):72-78. PubMed ID: 24070810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.
    Mah FS; O'Brien T; Kim T; Torkildsen G
    Curr Med Res Opin; 2008 Feb; 24(2):441-7. PubMed ID: 18167176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis.
    James IG; Campbell LM; Harrison JM; Fell PJ; Ellers-Lenz B; Petzold U
    Curr Med Res Opin; 2003; 19(4):313-20. PubMed ID: 12841924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
    Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.